The SCC international symposium focuses on latest highlights concerning the malignant transformation of stem cells in the blood and other organs, as well as new findings concerning the epigenetic regulation of healthy and diseased stem cells.
We award prizes to the three best posters and short talks
Understanding the role of stem-like cells in tumor initiation, progression, and therapy resistance.
Comparing normal developmental processes with oncogenic transformation and tumor heterogeneity.
Novel tools (e.g., organoids, CRISPR, AI) and their use in stem cell and cancer research.
Investigating how epigenetic modifications drive stem cell plasticity and cancer evolution.
The interplay between cancer stem cells, immune evasion, and immunotherapy approaches.
Metabolic reprogramming in stem cells and cancer cells as a therapeutic target.
Harnessing stem cells for tissue repair while avoiding oncogenic risks.
Advances in single-cell genomics, transcriptomics, and proteomics to dissect cellular heterogeneity.
Exploring how the cellular and molecular environment influences stem cell behavior and cancer development.
How cancer stem cells evade treatment and strategies to overcome resistance.
